Azithromycin vs Standard Care in Mild to Moderate COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Respiratory Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Azithromycin Versus Standard Care in Patients With Mild-to-Moderate COVID-19 (ATOMIC2): An Open-Label, Randomised Trial
Lancet Respir Med 2021 Jul 09;[EPub Ahead of Print], TSC Hinks, L Cureton, R Knight, A Wang, JL Cane, VS Barber, J Black, SJ Dutton, J Melhorn, M Jabeen, P Moss, R Garlapati, T Baron, G Johnson, F Cantle, D Clarke, S Elkhodair, J Underwood, D Lasserson, ID Pavord, S Morgan, D RichardsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.